Straits Times Index
3,332.80 -10.55 (-0.32%) Nikkei
39,583.08 +241.54 (+0.61%) Hang Seng
17,718.61 +2.14 (+0.01%) FTSE 100
8,164.12 -15.56 (-0.19%) Bitcoin USD
61,384.67 +508.71 (+0.84%) CMC Crypto 200
1,276.20 -7.63 (-0.59%)
SPGI Jul 2024 390.000 put
| Previous close | 0.5000 |
| Open | 0.5000 |
| Bid | 0.0000 |
| Ask | 1.0000 |
| Strike | 390.00 |
| Expiry date | 2024-07-19 |
| Day's range | 0.5000 - 0.5000 |
| Contract range | N/A |
| Volume | |
| Open interest | 10 |
PR NewswireS&P Global Schedules Second Quarter 2024 Earnings Announcement and Conference Call for Tuesday, July 30, 2024
S&P Global's (NYSE: SPGI) second quarter 2024 results will be issued on Tuesday, July 30, 2024 via news release at approximately 7:15 a.m. Eastern Daylight Time. The news release will be available at www.spglobal.com.
PR NewswireProtagonist Therapeutics Set to Join S&P SmallCap 600
Protagonist Therapeutics Inc. (NASD: PTGX) will replace Encore Wire Corp. (NASD: WIRE) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, July 3. S&P Europe 350 constituent Prysmian SpA (MTAA: PRY) is acquiring Encore Wire in a deal expected to be completed soon pending final conditions.
ReutersS&P Global announces insider Martina Cheung as CEO
Cheung, who has held multiple leadership roles at S&P Global in her 14-year stint, will succeed Douglas Peterson, the company's chief executive since 2013. S&P Global announced that retiring CEO Peterson will remain with the board until May 2025, and will be a special adviser to the company till Dec. 31, 2025. This trend bodes well for companies such as S&P Global, known for its rating agency business and stock market indexes.
